The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR -Mutant NSCLC Patients Treated with First-Line Osimertinib.

Kuan-Chih Chen,Yen-Hsiang Huang,Kuo-Hsuan Hsu,Jeng-Sen Tseng,Gee-Chen Chang,Tsung-Ying Yang

OncoTargets and therapy（2023）

引用 0|浏览11

暂无评分

摘要

Baseline serum NLR could act as an important prognostic marker for -mutant NSCLC patients receiving first-line osimertinib. A high NLR was associated with higher metastatic burden, more extrathoracic metastases, and therefore, a worse outcome.

查看译文

关键词

neutrophil-to-lymphocyte,egfr-mutant,first-line

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要